ClinicalTrials.Veeva

Menu

Role of Cord Blood Hormones and Epinephrine in the Development of Transient Tachypnea of the Newborn

A

Ankara University

Status

Completed

Conditions

Wet Lung

Study type

Observational

Funder types

Other

Identifiers

NCT01149928
08H3330006

Details and patient eligibility

About

In this prospective, cross-sectional study, the aim was to investigate the possible role of cord stress hormones; adrenocorticotropic hormone (ACTH), cortisol, epinephrine, sT3, sT4, and thyroid-stimulating hormone (TSH) in the development of Transient Tachypnea of the Newborn (TTN), via their modulatory effect on epithelial sodium channels and Na-K-ATPase.

Enrollment

70 patients

Sex

All

Ages

34 to 40 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Gestation age > 34 weeks
  • C/S delivered infants
  • Parental consent form signed

Exclusion criteria

  • Gestation age < 34 weeks
  • Maternal conditions that compromised fetal well-being (hypertensive disorder, diabetes, chorioamnionitis)
  • Intrauterine growth retardation
  • Congenital malformations
  • Absence of parental consent

Trial design

70 participants in 2 patient groups

C/S delivered, wet lung
C/S delivered, healthy infants

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems